BEAM is trading at $35.50, up 6.9% versus the comparison close of $33.20 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 BEAM extends move to 6.9% up
Beam Therapeutics Inc
Related News
BEAM
🔴 Beam Therapeutics is trading 4% down on October 14, 2026, amid broad market and sector weakness
BEAM
🟢 Beam Therapeutics is trading 4.38% up in pre-market after 40 mg cohort showed controlled fasting
BEAM
Beam Therapeutics Reports 15-Hour Fasts in GSDIa Trial
BEAM
🟢 Beam Therapeutics rises 5.6% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
BEAM